Clinical Trials In Oklahoma

Discover hundreds of clinical trials in Oklahoma.
Search clinical trials in Oklahoma by city, condition or phase.

e.g. Respiratory Diseases

Oklahoma•Healthy volunteers: No

Filter results

Results: 855

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Recruiting

Sponsor:

NRG Oncology

Location:

Oklahoma City, Anchorage, Fairbanks, Gilbertshow 358 more

Code:

NCT05896189

Conditions

Breast Cancer

Cognitive Impairments

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Arm 1: Computerized Cognitive Training-Global Stimulation Games

Arm 2: Computerized Cognitive Training-Neuroplasticity Games

A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Recruiting

Phase 3

Sponsor:

Bristol-Myers Squibb

Location:

Oklahoma City, Los Alamitos, San Diego, New Havenshow 20 more

Code:

NCT06045689

Conditions

Myelodysplastic Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Luspatercept

Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

Recruiting

Phase 2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Oklahoma City, Birmingham, Palo Alto, New Havenshow 53 more

Code:

NCT05303792

Conditions

B Acute Lymphoblastic Leukemia

B Lymphoblastic Lymphoma

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Vincristine

Dexamethasone

Inotuzumab Ozogamicin

Methotrexate

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Recruiting

Phase 1

Sponsor:

National Cancer Institute (NCI)

Location:

Oklahoma City, Orange, Gainesville, Shilohshow 9 more

Code:

NCT05803382

Conditions

Metastatic Colorectal Carcinoma

Metastatic Malignant Solid Neoplasm

Stage IV Colorectal Cancer AJCC v8

Unresectable Colorectal Carcinoma

Unresectable Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BET Bromodomain Inhibitor ZEN-3694

Biopsy

Biospecimen Collection

Capecitabine

Computed Tomography

Continuous Monitoring and Control of Hypoglycemia

Recruiting

Sponsor:

DexCom, Inc.

Location:

Oklahoma City, La Jolla, La Mesa, Sacramentoshow 20 more

Code:

NCT03340831

Conditions

Diabetes

Eligibility Criteria

Sex: All

Age: 2+

Healthy Volunteers: Not accepted

Interventions

Continuous Glucose Monitoring (CGM)

A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Recruiting

Phase 2

Sponsor:

Washington University School of Medicine

Location:

Oklahoma City, Saint Louis, Albuquerque

Code:

NCT05903131

Conditions

Endometrial Hyperplasia

Grade 1 Endometrial Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Telemedicine behavioral weight intervention

Progestin

Enhanced usual care

Levonorgestrel-releasing IUD.

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Recruiting

Phase 3

Sponsor:

Stealth BioTherapeutics Inc.

Location:

Edmond, Phoenix, Sun City, Huntington Beachshow 29 more

Code:

NCT06373731

Conditions

Age Related Macular Degeneration (ARMD)

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Elamipretide

Placebo

SPYRAL AFFIRM Global Study of RDN with the Symplicity Spyral RDN System in Subjects with Uncontrolled HTN

Recruiting

Sponsor:

Medtronic Vascular

Location:

Oklahoma City, Birmingham, Mesa, Phoenixshow 63 more

Code:

NCT05198674

Conditions

Hypertension

Vascular Diseases

Cardiovascular Diseases

Chronic Kidney Diseases

Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Renal Denervation (Symplicity Spyral™)

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Recruiting

Sponsor:

Abbott Medical Devices

Location:

Tulsa, Birmingham, Phoenix, Scottsdaleshow 60 more

Code:

NCT03433274

Conditions

Mitral Regurgitation

Mitral Insufficiency

Mitral Valve Insufficiency

Cardiovascular Diseases

Valve Disease, Heart

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tendyne Mitral Valve System

MitraClip System

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Oklahoma City, Lawton, Auburn, Berkeleyshow 99 more

Code:

NCT05111574

Conditions

Anal Melanoma

Bladder Melanoma

Cervical Melanoma

Esophageal Melanoma

Gallbladder Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Cabozantinib S-malate

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

Popular cities in Oklahoma

Oklahoma City

e.g. Respiratory Diseases

Oklahoma•Healthy volunteers: No

Filter results

Results: 855

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Recruiting

Sponsor:

NRG Oncology

Location:

Oklahoma City, Anchorage, Fairbanks, Gilbertshow 358 more

Code:

NCT05896189

Conditions

Breast Cancer

Cognitive Impairments

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Arm 1: Computerized Cognitive Training-Global Stimulation Games

Arm 2: Computerized Cognitive Training-Neuroplasticity Games

A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Recruiting

Phase 3

Sponsor:

Bristol-Myers Squibb

Location:

Oklahoma City, Los Alamitos, San Diego, New Havenshow 20 more

Code:

NCT06045689

Conditions

Myelodysplastic Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Luspatercept

Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

Recruiting

Phase 2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Oklahoma City, Birmingham, Palo Alto, New Havenshow 53 more

Code:

NCT05303792

Conditions

B Acute Lymphoblastic Leukemia

B Lymphoblastic Lymphoma

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Vincristine

Dexamethasone

Inotuzumab Ozogamicin

Methotrexate

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Recruiting

Phase 1

Sponsor:

National Cancer Institute (NCI)

Location:

Oklahoma City, Orange, Gainesville, Shilohshow 9 more

Code:

NCT05803382

Conditions

Metastatic Colorectal Carcinoma

Metastatic Malignant Solid Neoplasm

Stage IV Colorectal Cancer AJCC v8

Unresectable Colorectal Carcinoma

Unresectable Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BET Bromodomain Inhibitor ZEN-3694

Biopsy

Biospecimen Collection

Capecitabine

Computed Tomography

Continuous Monitoring and Control of Hypoglycemia

Recruiting

Sponsor:

DexCom, Inc.

Location:

Oklahoma City, La Jolla, La Mesa, Sacramentoshow 20 more

Code:

NCT03340831

Conditions

Diabetes

Eligibility Criteria

Sex: All

Age: 2+

Healthy Volunteers: Not accepted

Interventions

Continuous Glucose Monitoring (CGM)

A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Recruiting

Phase 2

Sponsor:

Washington University School of Medicine

Location:

Oklahoma City, Saint Louis, Albuquerque

Code:

NCT05903131

Conditions

Endometrial Hyperplasia

Grade 1 Endometrial Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Telemedicine behavioral weight intervention

Progestin

Enhanced usual care

Levonorgestrel-releasing IUD.

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Recruiting

Phase 3

Sponsor:

Stealth BioTherapeutics Inc.

Location:

Edmond, Phoenix, Sun City, Huntington Beachshow 29 more

Code:

NCT06373731

Conditions

Age Related Macular Degeneration (ARMD)

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Elamipretide

Placebo

SPYRAL AFFIRM Global Study of RDN with the Symplicity Spyral RDN System in Subjects with Uncontrolled HTN

Recruiting

Sponsor:

Medtronic Vascular

Location:

Oklahoma City, Birmingham, Mesa, Phoenixshow 63 more

Code:

NCT05198674

Conditions

Hypertension

Vascular Diseases

Cardiovascular Diseases

Chronic Kidney Diseases

Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Renal Denervation (Symplicity Spyral™)

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Recruiting

Sponsor:

Abbott Medical Devices

Location:

Tulsa, Birmingham, Phoenix, Scottsdaleshow 60 more

Code:

NCT03433274

Conditions

Mitral Regurgitation

Mitral Insufficiency

Mitral Valve Insufficiency

Cardiovascular Diseases

Valve Disease, Heart

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tendyne Mitral Valve System

MitraClip System

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Oklahoma City, Lawton, Auburn, Berkeleyshow 99 more

Code:

NCT05111574

Conditions

Anal Melanoma

Bladder Melanoma

Cervical Melanoma

Esophageal Melanoma

Gallbladder Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Cabozantinib S-malate

Computed Tomography

Echocardiography

Magnetic Resonance Imaging